Sildenafil is actually a potent and selective inhibitor of cGMP-distinct phosphodiesterase type 5 (PDE5), which can be answerable for degradation of cGMP in the corpus cavernosum. The molecular framework of sildenafil is comparable to that of cGMP and acts like a aggressive binding agent of PDE5 during the corpus cavernosum, resulting in additional